6 December 1994 Effect of the FDA on health care investments
Author Affiliations +
Proceedings Volume 2307, Health Care Technology Policy I: The Role of Technology in the Cost of Health Care; (1994) https://doi.org/10.1117/12.195462
Event: The Role of Technology in the Cost of Health Care, 1994, Arlington, VA, United States
Abstract
The cost of securing FDA approval has long been an important consideration in funding projects involving new medical technologies, but the more stringent regulatory behavior of the FDA in the past few years has led to a discernable decrease in the funding of start-up medical device companies. An abundance of anecdotal evidence, supported with surveys of venture capital firms, investment groups and medical device corporations, indicates a serious shortage of funds available for the development of certain medical technologies.
© (1994) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
David J. Cleary, "Effect of the FDA on health care investments", Proc. SPIE 2307, Health Care Technology Policy I: The Role of Technology in the Cost of Health Care, (6 December 1994); doi: 10.1117/12.195462; https://doi.org/10.1117/12.195462
PROCEEDINGS
5 PAGES


SHARE
RELATED CONTENT

Technology, human error, and standards
Proceedings of SPIE (October 27 1995)
Financial Analysis
Proceedings of SPIE (September 06 1988)
Problems caused by regulatory delays and regulation
Proceedings of SPIE (December 06 1994)

Back to Top